Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas

Carcinogenesis

Volumn 22, Issue 11, 2001, Pages 1801-1807

  Simpson, D J ^a   Fryer, A A ^a   Grossman, A B ^b   Wass, J A H ^c   Pfeifer, M ^d   Kros, J M ^e   Clayton, R N ^a   Farrell, W E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYCLIN D1; GUANINE; TUMOR MARKER;

ALLELE; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENE FREQUENCY; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; INTRON; MAJOR CLINICAL STUDY; MARKER GENE; POPULATION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT INDICATION;

EID: 0035161420     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.11.1801     Document Type: Article

References (23)

1. A genetic model for colorectal tumourigenesis
2. The molecular genetics of the multiple endocrine neoplasia syndrome
3. Pituitary neoplasia
4. Clinically non-functioning pituitary tumours are monoclonal in origin
5. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer
6. Perturbation of cell cycle regulators in human cancer
7. D type cyclins
8. Molecular genetics of pituitary tumour
9. A novel cyclin encoded by a bcl-1 linked candidate oncogene
10. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumours
11. Cyclin D1 and prognosis in human breast cancer
12. Expression of cyclin D1 and EMS1 in bladder tumours, relationship with chromosome 11q13 amplification
13. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
14. Molecular genetic studies of sporadic pituitary tumours
15. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker
16. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors
17. Alternate splicing produces a novel cyclin D1 transcript
18. Polymorphism in the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
19. Cyclin D1 protein expression and gene polymorphism in colorectal cancer
20. Chromosome 9p deletions in invasive and non-invasive non-functional pituitary adenomas. The deleted region involves markers outside of the MTS1 and MTS2 genes
21. Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with non-functioning adenomas but not somatotrophinomas
22. Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumour progression in human laryngeal carcinomas
23. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in head and neck squamous cell carcinoma